Literature DB >> 12384980

Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors.

Gregory N Prado1, Linda Taylor, Xiaofeng Zhou, Dennis Ricupero, Dale F Mierke, Peter Polgar.   

Abstract

Bradykinin (BK) is a potent short-lived effector belonging to a class of peptides known as kinins. It participates in inflammatory and vascular regulation and processes including angioedema, tissue permeability, vascular dilation, and smooth muscle contraction. BK exerts its biological effects through the activation of the bradykinin B2 receptor (BKB2R) which is G-protein-coupled and is generally constitutively expressed. Upon binding, the receptor is activated and transduces signal cascades which have become paradigms for the actions of the Galphai and Galphaq G-protein subunits. Following activation the receptor is then desensitized, endocytosed, and resensitized. The bradykinin B1 (BKB1R) is a closely related receptor. It is activated by desArg(10)-kallidin or desArg(9)-BK, metabolites of kallidin and BK, respectively. This receptor is induced following tissue injury or after treatment with bacterial endotoxins such as lipopolysacharide or cytokines such as interleukin-1 or tumor necrosis factor-alpha. In this review we will summarize the BKB2R and BKB1R mediated signal transduction pathways. We will then emphasize the relevance of key residues and domains of the intracellular regions of the BKB2R as they relate to modulating its function (signal transduction) and self-maintenance (desensitization, endocytosis, and resensitization). We will examine the features of the BKB1R gene promoter and its mRNA as these operate in the expression and self-maintenance of this inducible receptor. This communication will not cover areas discussed in earlier reviews pertaining to the actions of peptide analogs. For these we refer you to earlier reviews (Regoli and Barabé, 1980, Pharmacol Rev 32:1-46; Regoli et al., 1990, J Cardiovasc Pharmacol 15(Suppl 6):S30-S38; Regoli et al., 1993, Can J Physiol Pharmacol 71:556-557; Marceau, 1995, Immunopharmacology 30:1-26; Regoli et al., 1998, Eur J Pharmacol 348:1-10). Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384980     DOI: 10.1002/jcp.10175

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  36 in total

1.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

2.  Kinin receptor expression during Staphylococcus aureus infection.

Authors:  Sara H Bengtson; Stephen B Phagoo; Anna Norrby-Teglund; Lisa Påhlman; Matthias Mörgelin; Bruce L Zuraw; L M Fredrik Leeb-Lundberg; Heiko Herwald
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

Review 3.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

4.  C-terminus of ETA/ETB receptors regulate endothelin-1 signal transmission.

Authors:  Achani Yatawara; Jamie L Wilson; Linda Taylor; Peter Polgar; Dale F Mierke
Journal:  J Pept Sci       Date:  2013-02-25       Impact factor: 1.905

5.  Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission.

Authors:  Haibin Wang; Tatsuro Kohno; Fumimasa Amaya; Gary J Brenner; Nobuko Ito; Andrew Allchorne; Ru-Rong Ji; Clifford J Woolf
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

6.  Association of the human bradykinin B2 receptor gene with chronic renal failure.

Authors:  Lucyna Jozwiak; Andrzej Drop; Kinga Buraczynska; Piotr Ksiazek; Piotr Mierzicki; Monika Buraczynska
Journal:  Mol Diagn       Date:  2004

7.  Nerve growth factor sensitizes adult sympathetic neurons to the proinflammatory peptide bradykinin.

Authors:  Oscar Vivas; Martin Kruse; Bertil Hille
Journal:  J Neurosci       Date:  2014-09-03       Impact factor: 6.167

8.  Effect of two active compounds obtained from the essential oil of Cordia verbenacea on the acute inflammatory responses elicited by LPS in the rat paw.

Authors:  R Medeiros; G F Passos; C E Vitor; J Koepp; T L Mazzuco; L F Pianowski; M M Campos; J B Calixto
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

9.  Segmental expression of the bradykinin type 2 receptor in rat efferent ducts and epididymis and its role in the regulation of aquaporin 9.

Authors:  C Belleannée; N Da Silva; W W C Shum; M Marsolais; R Laprade; D Brown; S Breton
Journal:  Biol Reprod       Date:  2008-10-01       Impact factor: 4.285

Review 10.  Excitation and sensitization of nociceptors by bradykinin: what do we know?

Authors:  Kazue Mizumura; Takeshi Sugiura; Kimiaki Katanosaka; Ratan K Banik; Yasuko Kozaki
Journal:  Exp Brain Res       Date:  2009-04-26       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.